-
Product Insights
Clot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Analyst Opinions
What Opportunities do Planned Impulse Occasions Offer Food and Drinks Brands?
Opportunities for Food and Drinks Brands on Planned Impulse Occasions Report Overview Purchase decisions can generally be categorized into planned purchases or impulse purchases. However, there is a third category that is present at the intersection of these two purchase behaviors. "Planned impulse" purchases reflect elements of need-based purchasing as well as unplanned decisions in-store. It refers to an unintended change to a planned purchase triggered by a discount or promotion. The “What Opportunities Do Planned Impulse Occasions Offer Food...
-
Product Insights
Kudumane Mine
The Kudumane Mine is a manganese mine in South Africa. It is currently in operation. Empower your strategies with our Kudumane Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ecopipam Hydrochloride in Tourette Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ecopipam Hydrochloride in Tourette Syndrome Drug Details:Ecopipam hydrochloride (PSYRX-101) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HZA-018 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HZA-018 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HZA-018 in Marginal Zone B-cell Lymphoma Drug Details:HZA-018 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inobrodib in Relapsed Acute Myeloid Leukemia Drug Details: Inobrodib (CCS-1477) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilaroxazine in Psychosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brilaroxazine in Psychosis Drug Details: RP-5063 is under development for the treatment of schizophrenia, schizoaffective...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nivolumab in Myelodysplastic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab in Myelodysplastic Syndrome Drug Details: Nivolumab (Opdivo, Opdyta) is a human IgG4 anti-PD-1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nivolumab in Uterine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Uterine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab in Uterine Cancer Drug Details: Nivolumab (Opdivo, Opdyta) is a human...